drugset

drugset / Trial / NCT04979247

Intravenous Oliceridine and Opioid-related Complications

NCT04979247 ↗

Phase 4 Completed 204 enrolled The Cleveland Clinic

NaSingle-groupOpen-labelPrevention

Summary

The investigator will evaluate the side effects of oliceridine.

Timeline

Start: 2021-09-15
Primary completion: 2023-12-21
Completion: 2024-01-10

Publications

Sessler DI, Ayad S, Bakal O, Disher NS, Duran JA, Weingarten TN, Dahan A, Demitrack MA, Kim J, Khanna AK; VOLITION Study Team. Oliceridine for postoperative pain and opioid-related complications: The intravenous oliceridine and opioid-related complications (VOLITION) prospective cohort study. J Clin Anesth. 2025 Jul;105:111870. doi: 10.1016/j.jclinane.2025.111870. Epub 2025 May 29.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Oliceridine	Other / unclassified	0.35 mg	Intravenous

Indications

No indication recorded.